Total Payments
$17,311
2024 Payments
$2,350
Companies
66
Transactions
840
Medicare Patients
165
Medicare Billing
$19,019
Payment Breakdown by Category
Food & Beverage$16,880 (97.5%)
Education$333.71 (1.9%)
Other$97.67 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,880 | 824 | 97.5% |
| Education | $333.71 | 13 | 1.9% |
| Long term medical supply or device loan | $49.95 | 1 | 0.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47.72 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,738 | 65 | $0 (2024) |
| Novo Nordisk Inc | $1,393 | 92 | $0 (2024) |
| Amgen Inc. | $1,223 | 47 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,045 | 72 | $0 (2021) |
| Lilly USA, LLC | $836.07 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $801.28 | 40 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $779.61 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $710.75 | 35 | $0 (2024) |
| ABBVIE INC. | $707.36 | 44 | $0 (2024) |
| Amarin Pharma Inc. | $686.48 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,350 | 123 | Bayer Healthcare Pharmaceuticals Inc. ($271.32) |
| 2023 | $2,585 | 118 | Otsuka America Pharmaceutical, Inc. ($468.14) |
| 2022 | $2,294 | 108 | AstraZeneca Pharmaceuticals LP ($375.09) |
| 2021 | $2,493 | 121 | Amgen Inc. ($247.81) |
| 2020 | $1,951 | 93 | Amgen Inc. ($365.72) |
| 2019 | $2,072 | 112 | Sunovion Pharmaceuticals Inc. ($517.70) |
| 2018 | $1,836 | 85 | Sunovion Pharmaceuticals Inc. ($360.17) |
| 2017 | $1,730 | 80 | AstraZeneca Pharmaceuticals LP ($424.71) |
All Payment Transactions
840 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardio-renal | ||||||
| 12/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE INSULINX (Device) | Long term medical supply or device loan | In-kind items and services | $49.95 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.23 | General |
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 103 | 141 | $30,370 | $11,189 |
| 2020 | 2 | 62 | 129 | $13,107 | $7,831 |
Total Patients
165
Total Services
270
Medicare Billing
$19,019
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 78 | $19,500 | $7,114 | 36.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 20 | $6,800 | $2,479 | 36.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 23 | $3,910 | $1,550 | 39.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 20 | $160.00 | $45.00 | 28.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 45 | 108 | $7,857 | $6,248 | 79.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 21 | $5,250 | $1,582 | 30.1% |
About Dr. Elmer Smith, MD
Dr. Elmer Smith, MD is a Internal Medicine healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699793992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elmer Smith, MD has received a total of $17,311 in payments from pharmaceutical and medical device companies, with $2,350 received in 2024. These payments were reported across 840 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($16,880).
As a Medicare-enrolled provider, Smith has provided services to 165 Medicare beneficiaries, totaling 270 services with total Medicare billing of $19,019. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bedford, TX
- Active Since 07/17/2006
- Last Updated 11/04/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699793992
Products in Payments
- FARXIGA (Drug) $1,235
- REXULTI (Drug) $866.32
- JARDIANCE (Drug) $700.23
- Vascepa (Drug) $686.48
- Kerendia (Drug) $678.13
- Ozempic (Drug) $675.98
- VRAYLAR (Drug) $589.22
- LONHALA MAGNAIR (Drug) $501.05
- TRULICITY (Drug) $402.98
- Repatha (Biological) $392.84
- Otezla (Drug) $388.48
- Aimovig (Biological) $378.26
- ENTRESTO (Drug) $340.16
- APTIOM (Drug) $312.10
- Rybelsus (Drug) $261.24
- CAPLYTA (Drug) $259.44
- TRELEGY ELLIPTA (Drug) $257.64
- Korlym (Drug) $207.39
- Dayvigo (Drug) $204.96
- ANORO (Drug) $188.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bedford
Dr. Michael Delaughter, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Scott Greenberg, Md, MD
Internal Medicine — Payments: $171,246
Internal Medicine $171,246
Dr. Venkatesan Vidi, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $17,343
Internal Medicine $17,343
Paul Kim, Md, MD
Internal Medicine — Payments: $15,775
Internal Medicine $15,775
Alisa Thamwiwat, M.d, M.D
Internal Medicine — Payments: $13,867
Internal Medicine $13,867
Rey Marquino, Md, MD
Internal Medicine — Payments: $12,902
Internal Medicine $12,902